Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol
HIT Consultant
NOVEMBER 30, 2022
a power Visa and ultimately the government could not deny. A similar inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc.
Let's personalize your content